Evidence map›Paper›PMID 32690605›Full record

ArticleThe Journal of biological chemistry2020

The mechano-sensitive response of β1 integrin promotes SRC-positive late endosome recycling and activation of Yes-associated protein.

Marc R Block, Molly Brunner, Théo Ziegelmeyer, Dominique Lallemand, Mylène Pezet, Genevieve Chevalier, Philippe Rondé, Cécile Gauthier-Rouviere, Bernhard Wehrle-Haller, Daniel Bouvard

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. CSK-mediated signalling by integrins in cancer.Frontiers in cell and developmental biology · 2023
    Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Marc R BlockInstitute for Advanced Bioscience, Université Grenoble Alpes, La Tronche, France; Institut National de la Santé et la Recherche Médicale-INSERM U1209, La Tronche, France; CNRS UMR 5309, La Tronche, France.
Molly BrunnerInstitute for Advanced Bioscience, Université Grenoble Alpes, La Tronche, France; Institut National de la Santé et la Recherche Médicale-INSERM U1209, La Tronche, France; CNRS UMR 5309, La Tronche, France.
Théo ZiegelmeyerInstitute for Advanced Bioscience, Université Grenoble Alpes, La Tronche, France; Institut National de la Santé et la Recherche Médicale-INSERM U1209, La Tronche, France; CNRS UMR 5309, La Tronche, France.
Dominique LallemandInstitut Cochin-INSERM U1016, Université Paris Descartes, Paris, France.
Mylène PezetInstitute for Advanced Bioscience, Université Grenoble Alpes, La Tronche, France; Institut National de la Santé et la Recherche Médicale-INSERM U1209, La Tronche, France; CNRS UMR 5309, La Tronche, France.
Genevieve ChevalierInstitute for Advanced Bioscience, Université Grenoble Alpes, La Tronche, France; Institut National de la Santé et la Recherche Médicale-INSERM U1209, La Tronche, France; CNRS UMR 5309, La Tronche, France.
Philippe RondéLaboratoire de Bioimagerie et Pathologies, CNRS UMR 7021, Université de Strasbourg, Strasbourg, France.
Cécile Gauthier-RouviereMontpellier Cell Biology Research Center (CRBM), University of Montpellier, CNRS, Montpellier, France.
Bernhard Wehrle-HallerDepartment of Cell Physiology and Metabolism, Centre Médical Universitaire, University of Geneva, Geneva, Switzerland.
Daniel BouvardInstitute for Advanced Bioscience, Université Grenoble Alpes, La Tronche, France; Institut National de la Santé et la Recherche Médicale-INSERM U1209, La Tronche, France; CNRS UMR 5309, La Tronche, France. Electronic address: daniel.bouvard@univ-grenoble-alpes.fr.
Centre National de la Recherche Scientifique · FRInserm · FRUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yes-associated protein (YAP) signaling has emerged as a crucial pathway in several normal and pathological processes. Although the main upstream effectors that regulate its activity have been extensively studied, the role of the endosomal system has been far less characterized. Here, we identified the late endosomal/lysosomal adaptor MAPK and mTOR activator (LAMTOR) complex as an important regulator of YAP signaling in a preosteoblast cell line. We found that p18/LAMTOR1-mediated peripheral positioning of late endosomes allows delivery of SRC proto-oncogene, nonreceptor tyrosine kinase (SRC) to the plasma membrane and promotes activation of an SRC-dependent signaling cascade that controls YAP nuclear shuttling. Moreover, β1 integrin engagement and mechano-sensitive cues, such as external stiffness and related cell contractility, controlled LAMTOR targeting to the cell periphery and thereby late endosome recycling and had a major impact on YAP signaling. Our findings identify the late endosome recycling pathway as a key mechanism that controls YAP activity and explains YAP mechano-sensitivity.

Indexed as

AnimalsCell Cycle ProteinsCell LineEndosomesHEK293 CellsHumansIntegrin beta1MiceMice, KnockoutProto-Oncogene MasSignal Transductionsrc-Family KinasesTranscription FactorsCell Cycle ProteinsIntegrin beta1MAS1 protein, humanProto-Oncogene Massrc-Family KinasesTranscription FactorsYY1AP1 protein, humancell adhesioncell signalingextracellular matrix (ECM)LAMTOR complexlate endosomesmechanosensingSRC kinasevesicular traffickingYes-associated protein (YAP)

Identifiers

PMID32690605
PMCPMC7521633
OpenAlexW3044062688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.